Back

Relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine according to time of day of vaccination: a post-hoc analysis of the DANFLU-1 randomised clinical trial

31 August 2024 (17:00 - 17:50)
Organised by: Logo
Congress Presentation Part of: Cardiovascular health: from treatment strategies to lifestyle adherence Public Health ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Jacob Christensen

Gentofte Hospital - Copenhagen University Hospital, Hellerup (Denmark)

7 More presentations in this session

Presentation thumbnail
Real world economic evaluation of CT-FFR in patients with suspected coronary artery disease
Doctor J. Peper (Nieuwegein, NL)
Abstract Slides Video
Presentation thumbnail
Type 2 diabetes rather than the presence of significant coronary stenoses is associated with quality of life in angiographied coronary patients
Associate Professor H. Drexel (Feldkirch, AT) Doctor B. Larcher (Feldkirch, AT)
Abstract Slides Video
Presentation thumbnail
Practicing what you preach. Do cardiology trainees in the United Kingdom follow the lifestyle advice that they would give to patients?
Doctor C. Camm (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Free fatty acids and mortality among adults in the United States: a report from US National Health and Nutrition Examination Survey (NHANES)
Doctor M. Li (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Cost-effectiveness analysis of implementing the Nagasaki Acute Myocardial Infarction (AMI) secondary prevention clinical pathway
Doctor M. Kurobe (Nagasaki, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular health: from treatment strategies to lifestyle adherence

The Event

Event poster

ESC Congress 2024

31 August 2024 17:00 CET
You may be interested in
thumbnail
Congress Presentation
Effect of high-dose vs. standard-dose quadrivalent influenza vaccine on death and hospitalizations in older adults with cardiovascular disease: a prespecified analysis of the DANFLU-1 study
31 August 2024
thumbnail
Congress Presentation
TIME - The Treatment in Morning versus Evening study.
26 August 2022
thumbnail
Congress Presentation
Impact of a pneumococcal vaccination incentive campaign
30 August 2025
thumbnail
Congress Presentation
Panel discussion - ADVOR.
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources